NCT06117436View on ClinicalTrials.gov

Impact of Cilostazol Versus Cilostazol and Selenium Combination on the Healing of Diabetic Foot Ulcer Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

206

Participants

Timeline

Start Date

October 19, 2023

Primary Completion Date

December 30, 2024

Study Completion Date

January 30, 2025

Conditions
Wound Heal
Interventions
DRUG

Cilostazol

Cilostazol 100 MG oral tablet once daily antiplatelet, Selenium 200mcg tablet once daily, anti oxidant

DRUG

Selenium

Selenium 200 mcg oral tablet once daily

Trial Locations (1)

Unknown

National Institute of Diabetes and Endocrinology, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT06117436 - Impact of Cilostazol Versus Cilostazol and Selenium Combination on the Healing of Diabetic Foot Ulcer Patients | Biotech Hunter | Biotech Hunter